Novartis Receives Approval For Enzair Breezhaler

Novartis Receives Approval For Enzair Breezhaler

The European Commission (EC) has granted approval for Novartis’ Enzair Breezhaler, a drug therapy for uncontrolled asthma. The drug is utilized as a maintenance treatment for adults with asthma. “Novartis is working to reimagine medicine for people with uncontrolled...